7hon MSN
Meet the Beaten-Down Biotech Stock Cathie Wood Loves and Wall Street Says May Soar More Than 130%
Now, it’s worth noting Stock Advisor's total average return is 1,072% — a market-crushing outperformance compared to 194% for the S&P 500. Don’t miss out on the latest top 10 list, available when you ...
The Chosun Ilbo on MSN
FDA Speeds Up Custom Gene Therapy Approvals With Existing Data
Last May, people were thrilled to learn that a 7-month-old baby who became the first in the world to receive a personalized ...
AI is set to shake up the investment management industry, but Gene Munster says the right mix of these soft skills could help ...
Over the past two decades, synthetic biology has fueled advancements across a broad range of disciplines, including agriculture, bioremediation, biofuel production, and chemical manufacturing. Today, ...
A West Coast biotech entrepreneur says he’s secured $30 million to form a public-benefit company to study how to safely create genetically edited babies, marking the largest known investment into the ...
Chocolate prices have been rising due to complications in the supply chain, but Penn State researchers have made a ...
The U.S. government is divesting from mRNA vaccines, but will other uses of the technology be spared? In a time of ...
Cathy Tie, who launched her first biotech in SF's IndieBio, now leads Manhattan Genomics in controversial push to edit human ...
The neurologic disease called chronic traumatic encephalopathy or CTE has most often been found in people who experienced ...
New research posits that a genetic incompatibility between female offspring of humans and Neanderthals and their children ...
Seven years after the first gene-edited babies were revealed, biotech startup Manhattan Genomics is reviving the idea of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback